April 17, 2014 6:40 AM ET

Company Overview of University of California-San Francisco

Company Overview

University of California-San Francisco is an education institution offering programs such as biological, biomedical, pharmaceutical, nursing, social and behavioral sciences, dentistry, medicine, and nursing and pharmacy. The schools of the university include Continuing Medical Education, School of Dentistry, School of Medicine, School of Nursing, and School of Pharmacy. University of California- San Francisco was established in 1897 and is based in San Francisco, California. The university has endowment assets worth $873 million.

San Francisco, CA 94143

United States

Founded in 2007

Phone:

415-476-9000

Fax:

415-476-3428

Key Executives for University of California-San Francisco

Chancellor
Age: 56
Professor of Tumor Biology and Cancer Research
Age: 63
Executive Director of News
Executive Director of Global Health Sciences
Professor
Age: 63
Compensation as of Fiscal Year 2013.

University of California-San Francisco Key Developments

University of California, San Francisco Collaborates with Verliant Sciences to Advance Waste Reclamation and Renewable Waste-Derived Energy

Verliant Sciences and the University of California, San Francisco (UCSF) have entered into a multi-year collaborative research and development agreement for the analysis and separation of molecular constituents of various waste streams. This research is expected to have important waste reclamation and renewable energy, as well as biomedical, applications. The multi-year alliance will take a phased approach and will draw on the biomedical expertise of UCSF researchers, as well as the environmental research expertise, technology, and industry experience of Verliant's science team at every phase. Scientists expect the research to generate information that will expand the use of waste byproducts and increased digestion efficiency, ultimately resulting in greater waste diversion potential.

Quest Diagnostics and University of California, San Francisco Form Collaboration to Accelerate Translation of Biomedical Research into Advanced Diagnostics in Field of Precision Medicine, for Improved Patient Care, Treatment and Outcomes

Quest Diagnostics and the University of California, San Francisco have formed a collaboration to accelerate the translation of biomedical research into advanced diagnostics in the field of precision medicine, for improved patient care, treatment and outcomes. Initial clinical areas of focus include autism, oncology, neurology and women's health. The collaboration, which combines the research discoveries and capabilities of UCSF with the national testing database and technical and clinical development capability of Quest Diagnostics, has an overarching aim of enabling holistic and integrated diagnostic solutions that close gaps in care or enable new clinical value. Under the terms of the agreement, scientists will jointly research, develop and validate diagnostic innovations to solve specific clinical problems and provide actionable information to improve patient care. The organizations will focus on diagnostics to advance precision medicine, an emerging field of medical science that aims to integrate the most informative data from molecular, clinical, population and other research to create predictive, preventive and precise medical solutions for patients. Quest Diagnostics will independently develop and validate any lab-developed tests for clinical use that emerge from the collaboration's research. Researchers will utilize laboratory-based diagnostics, imaging procedures and population analysis based on Quest's national Health Trends database. The alliance is the first master agreement that UCSF's Office of Innovation, Technology and Alliances has signed with a clinical laboratory testing company and augments the university's efforts to translate laboratory research into new therapies. The broad agreement lays the groundwork for multiple projects between the two organizations. The collaboration is launching with two specific projects already underway. One project involves Quest's national database of molecular testing data to facilitate participation in research and development efforts related to genetic variations of autism, based on Quest's CGH microarray ClariSure(TM) technology, which can help identify genetic mutations associated with autism and other developmental disorders. While there currently is no treatment for autism, a test that aids its diagnosis could help identify individuals who might be appropriate candidates for research studies that could lead to future therapies. The second project aims to identify biomarkers to determine which children with glioma brain tumors may benefit from a drug that is currently available to treat the disease. That project will integrate molecular biomarker testing with advanced MRI imaging technologies. This project is the first phase of larger collaborative studies to develop and validate integrated care pathways, which would include laboratory diagnostics, imaging data and other clinical information to be used in the management of patients with brain cancer and neurological diseases. UCSF has been at the forefront of the movement toward precision medicine, for which former UCSF Chancellor Susan Desmond-Hellmann, MD, MPH, co-authored the initial National Academy of Sciences paper that defined the new field. That paper set the vision of harnessing the vast amounts of genetic, environmental and health data worldwide to make health care more predictive, precise and targeted.

UC San Francisco Announces Establishment of UCSF Health Workforce Research Center

UC San Francisco has been awarded one of three Cooperative Agreements from the U.S. Bureau of the Health Professions to establish the UCSF Health Workforce Research Center (HWRC). The task of the center will be to examine the supply, demand, distribution and capacity of the health care workforce to meet the needs of older adults and persons with disabilities, many of whom will be likely to prefer receiving long-term care at home or in community-based settings. Joanne Spetz will lead the UCSF HWRC with deputy director Susan Chapman, PhD, RN, associate professor in the Department of Social and Behavioral Sciences at the UCSF School of Nursing. The center represents collaboration among the Institute for Health Policy Studies, the UCSF Center for the Health Professions and the UCSF School of Nursing. Spetz and Chapman also are affiliated faculty at the Center for the Health Professions. The new center will actively engage all five of UCSF's health profession schools, and will draw from UCSF's deep bench of long-term care health policy researchers. Additional expertise will come from collaborations with colleagues from PHI and the George Washington University.

Similar Private Companies By Industry

Company Name Region
Global Insurance Network, Inc. United States
Cooperative Agricultural Producers, Inc. United States
Del Webb's Coventry Homes, Inc. United States
FCA Real Estate Holdings, LLC United States
Cambium Learning, Inc. United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact University of California-San Francisco, please visit www.ucsf.edu. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.